Skip to main content

Table 1 Blood parameters and patient demographic. SF-36 scores were analysed using participant questionnaire responses. Results from routine full blood analysis in CFS/ME patients and HC

From: Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients

 

CFS/ME

HC

P Value

Age (years)

42.5 ± 3.5

43.5 ± 3.9

0.699

Gender n(%)

 Male

1

1

1.000

 Female

5

5

 

 BMI (kg/m2)

24.04 ± 0.74

23.8 ± 1.46

0.589

WHODAS

47.4 ± 6.47

4.34 ± 3.68

0.002

SF-36

 General Health (%)

28.47 ± 5.63

75.69 ± 3.3

0.002

 Physical Functioning (%)

35.83 ± 8.89

95.83 ± 1.54

0.002

 Role Physical (%)

5.27 ± 4.09

97.92 ± 2.08

0.002

 Role Emotional (%)

70.48 ± 15.32

100 ± 0

0.180

 Social Functioning (%)

35.42 ± 13.85

98 ± 2

0.030

 Body Pain (%)

37 ± 14.12

94.58 ± 2.45

0.004

Pathology

 White Cell Count (× 109/L)

6.18 ± 0.38

6.15 ± 0.51

1.000

 Lymphocytes (× 109/L)

2.11 ± 0.22

1.85 ± 0.10

0.132

 Neutrophils (× 109/L)

3.24 ± 0.28

3.62 ± 0.10

0.589

 Monocytes (× 109/L)

0.52 ± 0.03

0.48 ± 0.08

0.699

 Eosinophils (× 109/L)

0.26 ± 0.10

0.15 ± 0.03

0.394

 Basophils (× 109/L)

0.05 ± 0.01

0.05 ± 0.01

0.937

 Platelet (× 109/L)

237 ± 8.99

269.33 ± 16.64

0.180

 Red Cell Count (× 1012/L)

4.49 ± 0.17

4.80 ± 0.31

0.485

 Haematocrit

0.40 ± 0.01

0.42 ± 0.02

0.394

 Haemoglobin (g/L)

137.17 ± 5.88

140.83 ± 5.17

0.485

  1. Data presented as mean ± SEM. Abbreviations: CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis; HC, healthy controls; BMI, body mass index; WHODAS: World Health Organization Disability Assessment Schedule